Giuseppe Spadaro Selected Research

Common Variable Immunodeficiency

1/2021	Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions.
12/2020	Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients.
10/2020	Immunoglobulins G modulate endothelial function and affect insulin sensitivity in humans.
3/2020	The Usefulness of Scintigraphic Studies in the Assessment of Asymptomatic Bowel Disease in Patients with Primary Antibody Diseases.
1/2020	Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders.
11/2019	Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency.
1/2019	Immunosuppressive therapy with rituximab in common variable immunodeficiency.
1/2019	Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy.
10/2018	Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
1/2018	Chronic Diarrhea in Common Variable Immunodeficiency: a Case Series and Review of the Literature.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Spadaro Research Topics

Disease

17	Asthma (Bronchial Asthma) 05/2022 - 01/2007
15	Common Variable Immunodeficiency 01/2021 - 05/2007
8	Infections 11/2021 - 05/2007
8	Primary Immunodeficiency Diseases 10/2021 - 06/2011
5	Neoplasms (Cancer) 12/2021 - 01/2018
5	Lung Diseases (Lung Disease) 05/2020 - 05/2007
4	Atopic Dermatitis (Atopic Eczema) 05/2022 - 01/2007
4	Rhinosinusitis 05/2022 - 01/2016
4	Bronchiectasis 01/2022 - 06/2011
4	Eosinophilia 06/2021 - 01/2016
3	Nasal Polyps (Nasal Polyp) 05/2022 - 01/2021
3	COVID-19 04/2022 - 10/2021
3	Hereditary Angioedemas 12/2021 - 01/2021
3	Bruton type agammaglobulinemia 11/2021 - 06/2011
3	Angioedema 04/2021 - 09/2016
3	Cytopenia 01/2021 - 01/2017
3	Inflammation (Inflammations) 03/2020 - 10/2003
3	Churg-Strauss Syndrome (Allergic Angiitis) 04/2017 - 01/2016
2	Mastocytosis 12/2021 - 08/2021
2	Polyps 06/2021 - 01/2021
2	Reinfection 01/2019 - 11/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018 - 03/2017
2	Pneumonia (Pneumonitis) 06/2011 - 05/2007
2	Anaphylaxis (Anaphylactic Shock) 01/2010 - 01/2004
1	Hypersensitivity (Allergy) 04/2022
1	Hodgkin Disease (Hodgkin's Disease) 12/2021
1	Rare Diseases (Rare Disease) 12/2021
1	Edema (Dropsy) 12/2021
1	Arthritis (Polyarthritis) 12/2021
1	Systemic Mastocytosis 08/2021
1	Vasculitis (Vasculitides) 06/2021
1	Urticaria (Hives) 04/2021
1	Weight Gain 04/2021
1	Splenomegaly 01/2021
1	Atherosclerosis 10/2020
1	Insulin Resistance 10/2020
1	Diarrhea 03/2020
1	Body Weight (Weight, Body) 03/2020
1	Rhinitis 01/2020
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2020
1	Respiratory Hypersensitivity 11/2019
1	Hepatomegaly 11/2019

Drug/Important Bio-Agent (IBA)

16	Immunoglobulins (Immunoglobulin)IBA 04/2022 - 05/2007
13	Immunoglobulin G (IgG)IBA 11/2021 - 06/2011
8	Immunoglobulin E (IgE)IBA 01/2022 - 01/2004
7	Monoclonal AntibodiesIBA 04/2022 - 01/2016
6	Immunoglobulin A (IgA)IBA 04/2022 - 06/2011
6	CytokinesIBA 11/2019 - 10/2003
5	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 01/2016
5	Intravenous Immunoglobulins (IVIG)FDA Link 04/2017 - 05/2007
4	VaccinesIBA 11/2021 - 11/2017
3	benralizumabIBA 01/2022 - 01/2021
3	Prednisone (Sone)FDA LinkGeneric 06/2021 - 01/2016
2	GlucocorticoidsIBA 05/2022 - 04/2017
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2019
2	AllergensIBA 01/2022 - 01/2007
2	BradykininIBA 12/2021 - 11/2020
2	BNT162 VaccineIBA 11/2021 - 10/2021
2	mepolizumabIBA 06/2021 - 01/2021
2	Biological ProductsIBA 01/2021 - 01/2018
2	tezepelumabIBA 11/2019 - 01/2018
2	Thymic Stromal LymphopoietinIBA 11/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 02/2019 - 01/2007
2	Rituximab (Mabthera)FDA Link 01/2019 - 01/2016
2	AdiponectinIBA 01/2019 - 01/2017
2	Omalizumab (Xolair)FDA Link 01/2017 - 01/2016
2	AnaphylatoxinsIBA 01/2010 - 01/2004
2	Protamines (Protamine Sulfate)FDA Link 01/2010 - 01/2004
2	Contrast MediaIBA 01/2010 - 01/2004
1	dupilumabIBA 05/2022
1	NivolumabIBA 12/2021
1	Vascular Endothelial Growth Factor CIBA 08/2021
1	Vascular Endothelial Growth Factor DIBA 08/2021
1	Codon (Codons)IBA 08/2021
1	Vascular Endothelial Growth FactorsIBA 08/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021
1	AngiopoietinsIBA 08/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Therapeutic UsesIBA 01/2021
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2020
1	G-Protein-Coupled Receptor Kinase 2IBA 11/2020
1	indium oxineIBA 03/2020
1	IonophoresIBA 01/2020
1	anti-IgE antibodiesIBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	Calcimycin (A23187)IBA 01/2020
1	leucyl-phenylalanineIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2020
1	LigandsIBA 01/2020
1	EnzymesIBA 11/2019

Therapy/Procedure

19	Therapeutics 04/2022 - 05/2007
4	Biological Therapy 12/2021 - 01/2019
2	Immunotherapy 02/2019 - 01/2016
1	Precision Medicine 04/2022
1	Ligation 01/2020